Cargando…
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
Ebola fever is an acute, highly contagious viral disease with a mortality rate that can reach 90%. There are currently no licensed therapeutic agents specific to Ebola in the world. Monoclonal antibodies (MAbs) with viral-neutralizing activity and high specificity to the Ebola virus glycoprotein (EB...
Autores principales: | Esmagambetov, I. B., Shcheblyakov, D. V., Egorova, D. A., Voronina, O. L., Derkaev, A. A., Voronina, D. V., Popova, O., Ryabova, E. I., Shcherbinin, D. N., Aksenova, E. I., Semenov, A. N., Kunda, M. S., Ryzhova, N. N., Zubkova, O. V., Tukhvatulin, A. I., Logunov, D. Yu., Naroditsky, B. S., Borisevich, S. V., Gintsburg, A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807537/ https://www.ncbi.nlm.nih.gov/pubmed/35127147 http://dx.doi.org/10.32607/actanaturae.11487 |
Ejemplares similares
-
Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses
por: Voronina, D. V., et al.
Publicado: (2021) -
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022) -
Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
por: Burmistrova, Daria A., et al.
Publicado: (2016) -
Virus-Vectored Ebola Vaccines
por: Dolzhikova, I.V., et al.
Publicado: (2017) -
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
por: Derkaev, Artem A., et al.
Publicado: (2022)